In one of the clinical trials, SELECT, patients who were treated with semaglutide experienced a 20-28% reduction in major adverse cardiovascular events (MACE) nonfatal myocardial infarction (MI), nonfatal stroke, and cardiovascular death
If you have leftover grilled chicken, this recipe is even easier
GLP-1 receptor agonists may also reduce inflammatory signaling associated with obesity
Her hair was pulled back into a messy bun, and she rocked black sunglasses while enjoying the sunny getaway
As policymakers debate coverage, clinicians weigh long-term strategies, and society argues over who deserves access, the voices in this study are a reminder that the story of GLP-1 medications was never only about weight loss as much as it is about agency
For more information, visit novonordisk-us.com, Facebook, Instagram, and X